Aprotinin in Neonates Undergoing Cardiopulmonary Bypass

NCT00469742 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 290

Last updated 2012-03-16

No results posted yet for this study

Summary

This is a retrospective chart review study. The purpose of this study is to review our experience at Children's Healthcare of Atlanta in neonates receiving aprotinin. We will examine the specific outcomes of renal dysfunction, thrombosis and mortality.

Conditions

  • Cardiopulmonary Bypass
  • Congenital Defects
  • Hemostasis

Sponsors & Collaborators

  • Children's Healthcare of Atlanta

    lead OTHER

Principal Investigators

  • Nina Guzzetta, MD · Emory University

Eligibility

Max Age
1 Month
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Completion
2008-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00469742 on ClinicalTrials.gov